Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Shoulder tendinopathy is a common condition that causes shoulder pain and limits daily activities. It often results from damage or overuse of the rotator cuff tendons. Treatment typically includes rest, physical therapy, anti-inflammatory medications, and sometimes injections.
This clinical trial aims to compare the effectiveness of two types of injections for treating simple shoulder tendinopathy:
Corticosteroid injections, which reduce inflammation and provide quick pain relief, but may have only short-term effects.
Platelet-Rich Plasma (PRP) injections, a newer treatment made from the patient's own blood, which may promote long-term healing.
The study is being conducted at the Rheumatology Department of Charles Nicolle Hospital in Tunis, Tunisia. A total of 60 adult patients with shoulder tendinopathy will be randomly assigned to receive either a corticosteroid injection or a PRP injection.
Participants will be evaluated before the injection (baseline), after one week, and after three months. The researchers will assess pain levels using a visual analog scale (VAS), and shoulder function using validated questionnaires (DASH and SPADI scores).
The goal is to determine which treatment provides better pain relief and functional improvement over time.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Corticosteroid Injection | Experimental | Participants in this arm will receive a single infiltration of corticosteroids into the affected shoulder tendon. Corticosteroids are anti-inflammatory medications commonly used to reduce pain and inflammation in tendinopathies. The injection aims to provide rapid pain relief and improve shoulder function. Patients will be monitored for pain reduction and functional improvement at one week and three months after the injection. |
|
| Platelet-Rich Plasma (PRP) Injection | Experimental | Participants in this arm will receive a single infiltration of Platelet-Rich Plasma (PRP) into the affected shoulder tendon. PRP is prepared from the patient's own blood and contains growth factors that may promote tissue healing and regeneration. This treatment aims to provide longer-term pain relief and functional improvement. Patients will be evaluated for pain and shoulder function at one week and three months following the injection. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Corticosteroid Injection | Procedure | This intervention consists of a single injection of corticosteroids administered directly into the affected tendon of the shoulder. Corticosteroids are anti-inflammatory drugs used to rapidly reduce inflammation and pain associated with tendinopathy. The injection is performed under aseptic conditions by a trained physician. The aim is to provide quick pain relief and improve shoulder function, although effects may be temporary. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in pain intensity measured by Visual Analog Scale (VAS) | The Visual Analog Scale (VAS) ranges from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain". Higher scores represent worse pain outcomes. | baseline, 1 week, 3 months |
| Change in shoulder function measured by the Disabilities of the Arm, Shoulder and Hand (DASH) score | The DASH score ranges from 0 to 100. Higher scores indicate greater disability (worse function). | baseline, 1 week and 3 months |
| Change in shoulder pain and disability measured by the Shoulder Pain and Disability Index (SPADI) | The SPADI score ranges from 0 to 100. Higher scores indicate greater pain and disability. | baseline, 1 week, 3 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Selma Bouden, Assistant doctor | Contact | 0021624685748 | selma.bouden@gmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Charles Nicolle Hospital | Recruiting | Tunis | Tunisia |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41848176 | Derived | Bouden S, Jebali C, Ben Dhia S, Rouached L, Saidane O, Mahmoud I, Tekaya R, Ben Tekaya A, Abdelmoula L. Shoulder injection of platelet-rich plasma versus corticosteroids in rotator cuff tendinopathies. Scand J Rheumatol. 2026 Mar 18:1-8. doi: 10.1080/03009742.2026.2620888. Online ahead of print. |
Not provided
Not provided
De-identified individual participant data (including clinical and demographic data) will be made available to qualified researchers upon reasonable request. Data will be shared after publication of the primary results. Requests can be submitted to the principal investigator, who will review and approve data sharing agreements to ensure participant privacy and compliance with ethical regulations.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000305 | Adrenal Cortex Hormones |
| ID | Term |
|---|---|
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| platelet-rich plasma injection | Procedure | This intervention involves a single injection of Platelet-Rich Plasma (PRP), which is prepared from the patient's own blood through a process of centrifugation to concentrate platelets. PRP contains growth factors that may promote tissue healing and regeneration. The injection is administered under aseptic conditions into the affected shoulder tendon by a trained physician. The goal is to enhance long-term recovery of tendon function and reduce pain. |
|